average weight loss on retatrutide Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts three gut-hormone targets at once. On the top dose, people lost an of 28% Retatrutide trial results in 28
Pay in 4 interest-free payments of $5.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

























